Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

This study has been completed.

Study NCT00052845 Information provided by National Cancer Institute (NCI)

First Received: January 24, 2003 Last Updated: November 9, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)